Ví dụ về việc sử dụng Taking statins trong Tiếng anh và bản dịch của chúng sang Tiếng việt
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Less than 1 percent of people have to stop taking statins because they develop liver problems.
In more than half of the identified cases,men recovered from ED after they stopped taking statins.
There is evidence that taking statins may even increase your risk for Lou Gehrig's disease.
Muscle pain anddamage One of the most common complaints of people taking statins is muscle pain.
There is even evidence to suggest that taking statins can increase your risk of developing Lou Gehrig's disease.
And that's why one of the biggest changes in thecholesterol guidelines could lead to more people taking statins.
Doctors said patients should not stop taking statins but should discuss any problems with their doctors.
There is no convincing medical evidence to suggest that coenzyme Q10(CoQ10)prevents muscle pain in people taking statins.
The researchers found that people who stopped taking statins had a 33% increase in the risk of requiring hospital admission for cardiovascular problems.
In the journal BMJ Open Diabetes Research& Care,they called for regular blood sugar tests of people taking statins.
The FDA warns on statin labels that some people taking statins have developed memory loss or confusion; these effects are reversed when the medication is halted.
The risk of very serious side effects is extremely low andcalculated in a few cases per million of patients taking statins.
If you are taking statins(e.g. atorvastatin) and have any of the following which may increase the risk of you developing muscle disease(weakness, wasting and pain).
Neurological side effects- The FDA warns on statin labels that some people have developed memory loss orconfusion while taking statins.
An unrelated studyconducted by Harvard argued that the cardiac benefits of taking statins outweigh the risk of developing diabetes in some patients.
For patients taking statins, the guidelines say they no longer need to get LDL cholesterol levels down to a specific target number- a significant departure from how doctors have treated cholesterol for years.
During this time, the researchers noted that 17,204 individuals(14.3%of the total number of participants) stopped taking statins altogether for at least 3 months.
The symptoms started after the patients began taking statins, and improved after statins were stopped, and then came back when therapy was restarted.
Because research is still limited on the long-term safety of red yeast rice,it's also not recommended for those currently taking statins or women who are pregnant or breastfeeding.
There's no reason for people to stop taking statins to manage their cholesterol, but it's extremely unlikely, for patients with small cell lung cancer, that taking statins will make any difference to their cancer treatment outcome.
It's true that observational studies haveshown increased cancer rates among patients taking statins, but these studies were small and not well-controlled.
While there is evidence to support older adults taking statins for secondary prevention of cardiovascular disease- such as to prevent a second heart attack or stroke- there is limited evidence on the risks and benefits of this age group taking the cholesterol-lowering medication to prevent a first cardiovascular event.
A large new study following thousands ofparticipants found that older people who stop taking statins have a significantly increased risk of hospital admission due to cardiovascular problems.
Philip Greenland and Robert Bonow note that there is“uncertainty and hesitation” in the guidelines regarding older people butsaid it appears that it is not necessary to stop taking statins at age 76 if you are already on them.
Guidelines from the American College of Cardiology andthe American Heart Association recommend that adults taking statins have a fasting lipid profile done 4 to 12 weeks after starting therapy and then every 3 to 12 months thereafter to assure that the drug is working.
All of these individuals reached the age of 75 years between 2012 and 2014,had no history of cardiovascular disease, and had been taking statins regularly in the 2 years prior to joining the study.
Phase 1 trial results were reported in 2012 in the New England Journal of Medicine.[1][18] A phase 3 trial of statin intolerant patients called ODYSSEY ran for 65 weeks.[19] Results were presented at the 2014 European Society of Cardiology meeting.[20]A 78-week study of alirocumab in 2341 people taking statins who were at high risk for cardiovascular events and had high LDL cholesterol levels was published in April 2015.